Sarcoidosis-associated pulmonary hypertension (SAPH) is an important complication of
advanced sarcoidosis. Over the past few years, there have been several studies dealing …

Sarcoidosis, a systemic granulomatous disease of undetermined etiology, is characterized
by a variable clinical presentation and course. During the past decade, advances have been …

Objective Pulmonary hypertension (PH) has been associated with increased mortality in
patients with advanced pulmonary sarcoidosis. Sarcoidosis-associated PH may be the result …

Introduction Sarcoidosis-associated pulmonary hypertension (SAPH) is associated with
reduced survival in single-centre studies. The international Registry for SAPH (ReSAPH) …

Background Sarcoidosis-associated pulmonary hypertension (SAPH) is a common problem
in patients with persistent dyspneic sarcoidosis. The objective of this study was to determine …

Background Riociguat is effective in delaying the time to clinical worsening (TCW) in
patients with groups 1 and 4 pulmonary hypertension. Research Question Is riociguat more …

Background Pulmonary hypertension (PH) is a common complication of sarcoidosis that is
associated with increased mortality. The pathogenesis of PH in sarcoidosis is uncertain, and …

Sarcoidosis is a highly variable granulomatous multisystem syndrome. It affects individuals
in the prime years of life; both the frequency and severity of sarcoidosis are greater in …

Fibrosing lung disorders include a large number of diseases with diverse behaviour.
Patients can die because of the progression of their illness, remain stable or even improve …

Methods Sarcoidosis patients with pulmonary hypertension and no evidence for left
ventricular dysfunction were enrolled in an open label, prospective study. Patients …